Methods for treatment with dimercaptosuccinic acid (dsma)

Details Methods for treatment with dimercaptosuccinic acid (dsma) Methods for treatment with dimercaptosuccinic acid (dsma)

A - Human Necessities

61

K

A61K 31/185 (2006.01) A61K 31/19 (2006.01)

Patent

CA 2151747

Methods for treatment of humans and other animals with dimercaptosuccinic acid (DMSA). DMSA is administered to reduce lev- els of silicon in blood and tissue, reduce blood pressure, improve kidney function, prevent or retard the progression of chronic renal failure, treat the accumulation of silicon in advanced kidney disease, decrease accumulation of reac- tive oxygen metabolites, increase superoxide dismutase activity, and/or prevent the onset or improve the current status of senile dementia or Alzheimer's disease.

Affiliated with

Also associated with

Rating

Methods for treatment with dimercaptosuccinic acid (dsma) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treatment with dimercaptosuccinic acid (dsma), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treatment with dimercaptosuccinic acid (dsma) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1931901